Clayton Crolius sold $17k of SONM
Chief Financial Officer at DNA X, Inc.. 11,634 shares at an average of $1.45, traded Apr 23, 2025, filed Apr 25, 2025.
Score components
- +22RoleCFO
- 0Trade size$17k at market
- +10Share of holdings soldSold 27% of holdings
- +15Cluster6 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -42.8%, 3m -55.9%, 6m -57.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001641172-25-006117, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 23, 2025 | SOpen-market sale Common Stock | -11,634 | $1.45 | $17k | 30,958 | Apr 25, 2025 |
Related signals
Other insiders at DNA X, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 57Moderate | SONMsell DNA X, Inc. | Laurence W Lytton owner | $1.3M 866,916 shares | -100% | |
| 46Moderate | DNA X, Inc. | Charles Becher See Remarks | $45k 31,326 shares | -33% | |
| 46Moderate | DNA X, Inc. | James S Cassano director | $34k 23,381 shares | -32% | |
| 46Moderate | DNA X, Inc. | Michael C Mulica Acting CEO | $40k 27,818 shares | -28% | |
| 46Moderate | DNA X, Inc. | Jack Steenstra director | $34k 23,381 shares | -32% | |
| 35Weak | DNA X, Inc. | Jeffrey Wang director | $6,493 4,478 shares | -17% | |
| 15Weak | SONMsell DNA X, Inc. | Michael C Mulica Acting CEO | $8,394 2,559 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.